Anti-CEACAM antibodies and uses thereof | Patent Number 11760801

US 11760801 B2
Application Number17019747
Publication NumberUS 20210095024 A1
Pendency3 years, 5 days
Filled DateSep 14, 2020
Priority DateSep 27, 2019
Publication DateApr 1, 2021
Expiration DateSep 26, 2039
Inventor/ApplicantsDouglas V. Dolfi
Cassandra L. Lowenstein
Raluca I. Verona
Wendell Lamar B Blackwell
Raluca I. VERONA
Wendell Lamar B BLACKWELL
Cassandra L. LOWENSTEIN
Douglas V. DOLFI
ExaminesSULLIVAN, DENNIS JOHN
Art Unit1642
Technology Center1600
Assignments
Janssen Biotech Inc.
Current
Janssen Biotech Inc.Johnson & Johnson
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.